Intratumoral Injection of PV-001-DV Plus DC in Patients With Melanoma

NCT03990493 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Melanoma

Interventions

BIOLOGICAL: Dengue Virus-1 #45AZ5 (PV-001-DV)
BIOLOGICAL: Autologous Monocyte-derived Lysate Pulsed Dendritic Cells (PV-001-DC)

Sponsor

PrimeVax Immuno-Oncology Inc.

Collaborators

[object Object]